Abstract

Cytometry and analytical methods in <scp>COVID</scp>‐19 diagnostics and potential treatment: A special issue on Cytometry Part A

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Safety of SARS-CoV-2 mRNA vaccines and effects of immunosuppressive drugs on adverse reactions in patients with rheumatic diseases
Karin Furukawa ... Toshihiro Nanki
European Journal of Internal Medicine | VOL. 115
Karin Furukawa, et. al.Karin Furukawa ... Toshihiro Nanki
16 Jun 2023
SARS-CoV-2 antibody response eight months after vaccination with mRNA vaccines. Influence of prior SARS-CoV-2 exposure
Jesús Fernando García-Cruces-Méndez ... María Piedad Del-Amo-Merino
European Journal of Internal Medicine | VOL. 97
Jesús Fernando García-Cruces-Méndez, et. al.Jesús Fernando García-Cruces-Méndez ... María Piedad Del-Amo-Merino
05 Jan 2022
Decision letter: Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
Mone Zaidi ... Jameel Iqbal
-
Mone Zaidi, et. al.Mone Zaidi ... Jameel Iqbal
09 Feb 2023
Editor's evaluation: Study of efficacy and longevity of immune response to third and fourth doses of COVID-19 vaccines in patients with cancer: A single arm clinical trial
Jameel Iqbal
-
Jameel IqbalJameel Iqbal
09 Feb 2023
View more papers

More From: Cytometry Part A

Paper Title
Journal
Date
Author
-
-
Cytometry Part A | VOL. -
--
01 May 2024
Issue Information ‐ TOC
-
Cytometry Part A | VOL. -
--
01 May 2024
Volume 105A, Number 5, May 2024 Cover Image
-
Cytometry Part A | VOL. -
--
01 May 2024
Issue Information ‐ TOC
-
Cytometry Part A | VOL. 105
--
01 Apr 2024
View more papers